U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

ATAC-Seq in LNCaP cell line with GSK treatment and VEH control

(Submitter supplied) We show in prostate cancer cells that LSD1 co-localizes with FOXA1 and active enhancer markers, and that LSD1 inhibition globally disrupts FOXA1 chromatin binding.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
4 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE148925
ID:
200148925
2.

Lineage-specific chromatin binding of FOXA1 is regulated by LSD1-mediated demethylation

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing
Platforms:
GPL16791 GPL11154
62 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE149007
ID:
200149007
3.

ChIP-Seq for FOXA2 in PC3 cell line with GSK treatment and VEH control

(Submitter supplied) We show in prostate cancer cells that LSD1 co-localizes with FOXA1 and active enhancer markers, and that LSD1 inhibition globally disrupts FOXA1 chromatin binding.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
4 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE148982
ID:
200148982
4.

ChIP-Seq for HOXB13 in LNCaP cell line with GSK treatment and VEH control

(Submitter supplied) We show in prostate cancer cells that LSD1 co-localizes with FOXA1 and active enhancer markers, and that LSD1 inhibition globally disrupts FOXA1 chromatin binding.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
4 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE148928
ID:
200148928
5.

ChIP-Seq for FOXA1 in LNCaP cell line with GSK treatment and VEH control

(Submitter supplied) We show in prostate cancer cells that LSD1 co-localizes with FOXA1 and active enhancer markers, and that LSD1 inhibition globally disrupts FOXA1 chromatin binding.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL11154
4 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE148926
ID:
200148926
6.

SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL30173 GPL16791
17 Samples
Download data: BED, BW
Series
Accession:
GSE218094
ID:
200218094
7.

SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1 [RNA-seq]

(Submitter supplied) To determine the transcriptional impact of SETD7,MLL1 silencing in CRPC cells, we performed an RNA-seq analysis in those 22Rv1 stable cell lines (under hormone-depleted conditions)
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL30173 GPL16791
10 Samples
Download data: TXT
Series
Accession:
GSE218093
ID:
200218093
8.

SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1 [ChIP-seq]

(Submitter supplied) We recently reported that in prostate cancer LSD1 can demethylate the lysine 270 of FOXA1 to stabilize FOXA1 chromatin binding and thus can enhance the activities of AR and other transcription factors that require FOXA1 as a pioneer factor. However, the methyltransferase that can methylate FOXA1 and negatively regulate the LSD1-FOXA1 oncogenic axis remains unknown. SETD7 is initially identified as a transcriptional activator through methylating histone 3 lysine 4 but can also function as a methyltransferase on other non-histone substrates. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL30173 GPL16791
7 Samples
Download data: BED, BW
Series
Accession:
GSE218092
ID:
200218092
9.

LSD1 inhibition disrupts super-enhancer activities in CRPC

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing
Platforms:
GPL30173 GPL16791 GPL18573
58 Samples
Download data: MTX, TSV
Series
Accession:
GSE209889
ID:
200209889
10.

LSD1 inhibition disrupts super-enhancer activities in CRPC [scRNA-seq]

(Submitter supplied) Our studies revealed a novel oncogenic function of LSD1 in driving PCa progression by activating MYC signaling and mediating CRPC SEs activities, cotargeting LSD1 and BRD4 achieved significant synergistic effects in repressing CRPC tumor growth
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
2 Samples
Download data: MTX, TSV
Series
Accession:
GSE209888
ID:
200209888
11.

LSD1 inhibition disrupts super-enhancer activities in CRPC [RNA-seq]

(Submitter supplied) Our studies revealed a novel oncogenic function of LSD1 in driving PCa progression by activating MYC signaling and mediating CRPC SEs activities, cotargeting LSD1 and BRD4 achieved significant synergistic effects in repressing CRPC tumor growth
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL30173 GPL16791
54 Samples
Download data: TXT
Series
Accession:
GSE209887
ID:
200209887
12.

LSD1 inhibition disrupts super-enhancer activities in CRPC [ChIP-seq]

(Submitter supplied) Our studies revealed a novel oncogenic function of LSD1 in driving PCa progression by activating MYC signaling and mediating CRPC SEs activities, cotargeting LSD1 and BRD4 achieved significant synergistic effects in repressing CRPC tumor growth
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
2 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE209886
ID:
200209886
13.

Distinct structural classes of activating FOXA1 alterations in prostate cancer progression

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
61 Samples
Download data: BED, BW
Series
Accession:
GSE123625
ID:
200123625
14.

Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq]

(Submitter supplied) Expression profiles of 22RV1 prostate cancer cells following FOXA1 genetic engineering and or TLE3 knock-down
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL16791
12 Samples
Download data: CSV, GTF
Series
Accession:
GSE123619
ID:
200123619
15.

Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [ChIP-Seq]

(Submitter supplied) Chromatin binding profiles for FOXA1, AR, and TLE3 in prostate cancer cell lines with different FOXA1 genotypes. Full-length and truncated forms of FOXA1 are distinguished by C-terminal and N-terminal antibodies.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
49 Samples
Download data: BED, BW
Series
Accession:
GSE123618
ID:
200123618
16.

Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity

(Submitter supplied) Lysine Specific Demethylase 1 (LSD1, KDM1A) functions as a transcriptional corepressor through demethylation of histone 3 lysine 4 (H3K4), but has coactivator function on some genes through unclear mechanisms. We show that LSD1, interacting with CoREST, associates with and coactivates androgen receptor (AR) on a large fraction of androgen-stimulated genes. A subset of these AR/LSD1-associated enhancer sites have histone 3 threonine 6 phosphorylation (H3T6ph), and these sites are further enriched for androgen-stimulated genes. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing
Platform:
GPL15433
5 Samples
Download data: BED, TXT
17.

FOXA2/AP-1 drives prostate cancer lineage plasticity

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens; Mus musculus
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL18573 GPL30172 GPL30173
101 Samples
Download data: BED, BIGWIG, BW
Series
Accession:
GSE232555
ID:
200232555
18.

FOXA2/AP-1 drives prostate cancer lineage plasticity [RNA-seq]

(Submitter supplied) FOXA (Forkhead Box Protein A) family proteins function as pioneer transcription factors by loosening the compact chromatin structure and facilitating access for other transcription factors. The role of FOXA1 has been intensively studied in normal prostate epithelial cells and the adenocarcinoma subtype of prostate cancer (PCa) where it acts as a critical pioneer factor for the chromatin binding of androgen receptor (AR). more...
Organism:
Homo sapiens; Mus musculus
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL30173 GPL30172
61 Samples
Download data: TXT
Series
Accession:
GSE232554
ID:
200232554
19.

FOXA2/AP-1 drives prostate cancer lineage plasticity [PDX ChIP-seq]

(Submitter supplied) FOXA (Forkhead Box Protein A) family proteins function as pioneer transcription factors by loosening the compact chromatin structure and facilitating access for other transcription factors. The role of FOXA1 has been intensively studied in normal prostate epithelial cells and the adenocarcinoma subtype of prostate cancer (PCa) where it acts as a critical pioneer factor for the chromatin binding of androgen receptor (AR). more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL18573
16 Samples
Download data: BIGWIG
Series
Accession:
GSE232553
ID:
200232553
20.

FOXA2/AP-1 drives prostate cancer lineage plasticity [ChIP-seq]

(Submitter supplied) FOXA (Forkhead Box Protein A) family proteins function as pioneer transcription factors by loosening the compact chromatin structure and facilitating access for other transcription factors. The role of FOXA1 has been intensively studied in normal prostate epithelial cells and the adenocarcinoma subtype of prostate cancer (PCa) where it acts as a critical pioneer factor for the chromatin binding of androgen receptor (AR). more...
Organism:
Mus musculus; Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL30173 GPL18573 GPL30172
24 Samples
Download data: BED, BW
Series
Accession:
GSE232552
ID:
200232552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_668a018549fc8a23254eb54b|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center